Evaluation of the Effectiveness of Day Hospital Care for Adolescents With Anxious School Refusal

NCT ID: NCT07020013

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to evaluate the benefit of day care in a child psychiatric hospital on the return to school and on the development of child psychiatric disorders associated with Anxious Social Refusal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, longitudinal, single-center observational cohort study carried out on a population of patients followed in a day hospital for anxious school refusal.

Participating physicians will have the opportunity to recruit their patients over a 12-month period. All enrolled patients will be followed for a minimum of 10 months. The study will be completed as soon as the last enrolled patient has completed a final assessment.

Aside from the baseline visit, each patient will be assessed only once at 10 months. During each patient visit with the investigating physician, the physician will complete an assessment on the electronic CRF.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

School Phobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 12 to 18 years
* Patients with anxious school refusal, defined by a score ≥ 41 on the SCREEN scale
* Patients receiving day hospital care
* Patients who have been informed and whose parents (or holder(s) of parental authority) have agreed to their participation in the study and have not objected to the use of their health data

Exclusion Criteria

* Patients with a mental disability or any other reason that may hinder the understanding or strict application of the protocol
* Patients not affiliated with the French social security system
* Patients under guardianship
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique des 3 cyprès

La Penne-sur-Huveaune, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

solal STORA, MD

Role: CONTACT

04 28 63 16 01 ext. 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Solal STORA, MD

Role: primary

04 28 63 16 01 ext. 33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00523-46

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment for Specific Phobias in Children
NCT00051220 COMPLETED PHASE1/PHASE2
Fluoxetine for Anxious Children
NCT00000381 COMPLETED PHASE3
Treatment for Anxiety in Children
NCT00000389 COMPLETED PHASE3
Glucocorticoid Treatment for Social Phobia
NCT01574014 TERMINATED PHASE2
Partners in Caring for Anxious Youth
NCT04598230 ACTIVE_NOT_RECRUITING PHASE3